BNP Paribas Financial Markets
CTXR icon

BNP Paribas Financial Markets’s Citius Pharmaceuticals CTXR Stock Holding History

BNP Paribas Financial Markets’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65 Hold
107
– – ﹤0.01% 5814
2026
Q1 		$96 Hold
107
– – ﹤0.01% 5686
2025
Q4 		$83 Hold
107
– – ﹤0.01% 5624
2025
Q3 		$133 Hold
107
– – ﹤0.01% 5420
2025
Q2 		$170 Hold
107
– – ﹤0.01% 5296
2025
Q1 		$159 Sell
107
-14
-12% -$34 ﹤0.01% 5227
2024
Q4 		$484 Buy
121
+2
+2% +$13 ﹤0.01% 5177
2024
Q3 		$1.49K Hold
119
– – ﹤0.01% 3914
2024
Q2 		$1.74K Sell
119
-2,666
-96% -$47.8K ﹤0.01% 3821
2024
Q1 		$62.5K Buy
2,785
+1,308
+89% +$23.9K ﹤0.01% 3541
2023
Q4 		$27.9K Buy
1,477
+552
+60% +$10.5K ﹤0.01% 3638
2023
Q3 		$15.8K Sell
925
-409
-31% -$9.72K ﹤0.01% 3583
2023
Q2 		$40K Buy
1,334
+1,282
+2,465% +$42.2K ﹤0.01% 3523
2023
Q1 		$1.51K Sell
52
-408
-89% -$11.8K ﹤0.01% 3656
2022
Q4 		$9.09K Sell
460
-2
-0.4% -$55 ﹤0.01% 3622
2022
Q3 		$14K Sell
462
-423
-48% -$11.6K ﹤0.01% 4140
2022
Q2 		$20.4K Buy
885
+331
+60% +$9.07K ﹤0.01% 3691
2022
Q1 		$24.8K Sell
554
-1,223
-69% -$48.3K ﹤0.01% 3696
2021
Q4 		$68.4K Buy
1,777
+685
+63% +$31.1K ﹤0.01% 3685
2021
Q3 		$55.4K Buy
1,092
+612
+128% +$30.7K ﹤0.01% 3489
2021
Q2 		$41.8K Buy
+480
New +$28.8K ﹤0.01% 3325

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
BW
BostonPremier Wealth Hanover, Massachusetts $235M AUM 31.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

BNP Paribas Financial Markets's CTXR Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Citius Pharmaceuticals (CTXR) position steady in Q2 2026 at 107 shares worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #5814.

BNP Paribas Financial Markets first reported a position in CTXR in Q2 2021 and has held it in 21 quarters since. The position peaked at $68.4K in Q4 2021. 32 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • BNP Paribas Financial Markets held 107 shares of Citius Pharmaceuticals worth $65 as of Q2 2026.
  • BNP Paribas Financial Markets left its Citius Pharmaceuticals share count unchanged in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5814 holding.
  • BNP Paribas Financial Markets first reported a position in Citius Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • BNP Paribas Financial Markets's Citius Pharmaceuticals position peaked at $68.4K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.